Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells

Published:2018-07 Issue:2 Volume:24 Page:379-390.e6
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zhao Yunlong,Harrison Devin L.,Song Yuran,Ji Jie,Huang Jun,Hui Enfu

Funder

NINDS

UCSD

NIH

NSF

CRI Irvington Postdoctoral

Searle

Pew Biomedical

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer;Badoual;Cancer Res.,2013

2. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients;Baitsch;J. Clin. Invest.,2011

3. PD-L1 interacts specifically with B7-1 to inhibit T cell proliferation;Butte;Immunity,2007

4. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma;Carreras;J. Clin. Oncol.,2009

5. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity,2013

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors;International Journal of Molecular Sciences;2024-09-06

2. Therapeutic potential of cis-targeting bispecific antibodies;Cell Chemical Biology;2024-08

3. Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2);Journal for ImmunoTherapy of Cancer;2024-08

4. Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice;Cells;2024-07-15

5. New expression of PD-L1 on activated CD4+ T cells opens up new opportunities for cell interactions and signaling;Human Immunology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3